Her2-negative Archives - European Biotechnology Magazine

Tag Archive for: Her2-negative

Roche presents details on breast cancer pill giredestrant

Roche has unveiled detailed data for its oral selective estrogen receptor degrader (SERD), giredestrant, at the 2025 San Antonio Breast Cancer Symposium.

12 December 2025

Roche presents details on breast cancer pill giredestrant

Revier launches with €6M to develop novel cardiom...

Roche licenses Hanmi obesity drug for up to $2.3B

Hansa takes first step toward US Nasdaq listing

Stay up to date every week with the european biotechnology newsletter.

Stay up to date every week with the european biotechnology newsletter.

Tag Archive for: Her2-negative